Tc 99m RP 128

Drug Profile

Tc 99m RP 128

Alternative Names: 99mTc RP 128

Latest Information Update: 27 Aug 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bracco
  • Class Peptide diagnostics; Radiopharmaceutical diagnostics
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Crohn's disease; Rheumatoid arthritis

Most Recent Events

  • 27 Aug 2007 Discontinued - Phase-II for Crohn's disease diagnosis and rheumatoid arthritis diagnosis in Canada (unspecified route)
  • 27 Aug 2007 Discontinued - Phase-II for Crohn's disease diagnosis and rheumatoid arthritis diagnosis in European Union (unspecified route)
  • 28 Jan 1999 Phase-II clinical trials for Crohn's disease diagnosis and rheumatoid arthritis diagnosis in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top